WILMINGTON – NiKang Therapeutics, a clinical stage biotech startup focused on small molecule cancer treatments, recently closed a $200 million Series C financing round, one of the largest such venture […]
© 2023 Delaware Business Times
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.
SUMMER FLASH SALE!
Subscribe to Delaware Business Times and save 50%